Parkland, Fla., students calling for stricter gun laws will be heard at the polls, according to one Florida congresswoman. “People are going to be hard-pressed running for office this year [if they] are not for real solutions that include making sure that we get weapons of war out of the hands of civilians,” said Rep. Debbie Wasserman Schultz (D-FL). “Voters need to make sure that...if we can’t get these kinds of laws passed to protect our people, then we need to elect people across this country who will.” The Valentine’s Day attack has led to a wave of activism from students both in Parkland and across the nation. Some right-leaning politicians have softened their stance, expressing support for stronger background checks, banning “bump stocks”, and increasing the legal age limit for purchasing a gun. But Wasserman Schultz says words are not enough. She vows that she and her Democratic colleagues will “hold the Republican majority’s feet to the fire.” While the GOP does currently hold an advantage in both houses of Congress, some pundits believe that Democrats could regain a lead in this year’s midterms in November. For the full interview, [click here](https://cheddar.com/videos/congresswoman-debbie-wasserman-schultz-d-fl-talks-gun-reform-and-2018).

Share:
More In Politics
Skydio CEO On Russia-US Drone Collision
Adam Bry, co-founder and CEO of drone manufacturer Skydio, joined Cheddar News to discuss the company's latest funding round and the Russia-US drone collision.
Fed Set to Launch Digital Payments System Over the Summer
The Federal Reserve on Wednesday evening said its long-awaited digital payment system, the FedNow Service, will start operating in July. The service is designed to provide a national platform for financial institutions to settle payments in real-time and at lower cost. That could include large banks, payment processors, and the U.S. Treasury.
Long-Used US Abortion Pill Under Threat in Texas Lawsuit
A federal judge in Texas raised questions Wednesday about a Christian group's effort to overturn the decades-old U.S. approval of a leading abortion drug, in a case that could threaten the country's most common method for ending pregnancies.
Load More